Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Chemotherapy With Bevacizumab for Advanced Breast Cancer
NCT00083031Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jul 2003
- Primary completion
- Aug 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Dana-Farber Cancer Institute. Started Jul 2003; status: completed.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00083031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083031.